Myanmar vs Venezuela, Bolivarian Republic of: Tuberculosis treatment success rate
Myanmar
84.0%
in 2023
Venezuela, Bolivarian Republic of
84.0%
in 2023
Myanmar rank
98th
Venezuela, Bolivarian Republic of rank
98th
Tuberculosis treatment success rate over time
- Myanmar
- Venezuela, Bolivarian Republic of
How they compare
Myanmar currently reports 84.0% against 84.0% in Venezuela, Bolivarian Republic of, a difference of 0.0%.
The two have swapped places 11 times across 30 shared years of data; in 1994 it was Myanmar ahead.
Myanmar ranks 98th and Venezuela, Bolivarian Republic of ranks 98th of 206 countries.
Myanmar has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Myanmar | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 78.0% | 76.2% | 1.8% | Myanmar |
| 2000s | 82.5% | 81.3% | 1.2% | Myanmar |
| 2010s | 87.7% | 81.7% | 6.0% | Myanmar |
| 2020s | 86.5% | 84.0% | 2.5% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Myanmar or Venezuela, Bolivarian Republic of?
- Myanmar, at 84.0% against 84.0% in Venezuela, Bolivarian Republic of as of 2023.
- What is the difference in tuberculosis treatment success rate between Myanmar and Venezuela, Bolivarian Republic of?
- 0.0%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Venezuela, Bolivarian Republic of?
- 30 years are reported by both, from 1994 to 2023.
- How do Myanmar and Venezuela, Bolivarian Republic of rank globally for tuberculosis treatment success rate?
- Myanmar ranks 98th and Venezuela, Bolivarian Republic of ranks 98th of 206 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.